Article in Microbiology spectrum, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registry
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what money
Authors and funding
15 authors.
Endrews Delbaje *Faculdade de Ciências Farmacêuticas de Ribeirão Preto, Universidade de São Paulo, Ribeirao Preto, Brazil.ORCID 0000-0002-0313-9046
Laís Pontes *Faculdade de Ciências Farmacêuticas de Ribeirão Preto, Universidade de São Paulo, Ribeirao Preto, Brazil.
Marcela SavoldiFaculdade de Ciências Farmacêuticas de Ribeirão Preto, Universidade de São Paulo, Ribeirao Preto, Brazil.
Sarah SedikDivision of Infectious Diseases, Department of Internal Medicine, Medical University of Graz, Graz, Austria.ORCID 0009-0002-3070-2508
Karl DichtlDiagnosic and Research Institute for Hygiene, Microbiology and Environmental Medicine, Medical University of Graz, Graz, Austria.
Martin HoeniglDivision of Infectious Diseases, Department of Internal Medicine, Medical University of Graz, Graz, Austria.
Cornelia Lass-FlörlInstitute of Hygiene and Medical Microbiology, Medical University of Innsbruck, Innsbruck, Austria.ORCID 0000-0002-2946-7785
Cristina Silva PereiraInstituto de Tecnologia Química e Biológica António Xavier, NOVA University Lisbon, Oeiras, Portugal.ORCID 0000-0002-6750-1593
Angélica Zaninelli SchreiberSchool of Medical Sciences - University of Campinas, Campinas, State of São Paulo, Brazil.ORCID 0000-0002-5095-5054
Antonis RokasDepartment of Biological Sciences and Evolutionary Studies Initiative, Vanderbilt University, Nashville, Tennessee, USA.ORCID 0000-0002-7248-6551
Ling LuJiangsu Key Laboratory for Pathogens and Ecosystems, Jiangsu Engineering and Technology Research Centre for Microbiology; College of Life Sciences, Nanjing Normal University, Nanjing, China.ORCID 0000-0002-2891-7326
Júlio César Jeronimo BarbosaInstituto de Química, Universidade Estadual de Campinas (Unicamp), São Paulo, Brazil.ORCID 0000-0001-8831-831X
Taícia FillInstituto de Química, Universidade Estadual de Campinas (Unicamp), São Paulo, Brazil.
Thaila Fernanda Dos ReisFaculdade de Ciências Farmacêuticas de Ribeirão Preto, Universidade de São Paulo, Ribeirao Preto, Brazil.
Gustavo H GoldmanFaculdade de Ciências Farmacêuticas de Ribeirão Preto, Universidade de São Paulo, Ribeirao Preto, Brazil.ORCID 0000-0002-2986-350X
Funding
Fundação de Amparo à Pesquisa do Estado de São Paulo
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.
Evidence that increased azole persistence and stress resistance precede the · full record | OpenQuestion